Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Single-arm, Non-interventional Regulatory Post- Marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

NCT06283641 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06283641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06283641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Single-arm, Non-interventional Regulatory Post- Marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
April 8, 2024
Completion date
January 13, 2025
Enrollment
300 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

obesity